OCUGEN, INC. Other Noncash Income (Expense)
OCUGEN, INC. (OCGN) reported Other Noncash Income (Expense) of -$21.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- OCUGEN, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$11.00K.
- OCUGEN, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$10.00K.
- OCUGEN, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$1.01M.
- OCUGEN, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$9.00K.
- OCUGEN, INC. other noncash income (expense) for fiscal 2025 was -$1.04M.
- OCUGEN, INC. other noncash income (expense) for fiscal 2024 was -$37.00K.
- OCUGEN, INC. other noncash income (expense) for fiscal 2023 was -$46.00K, a 106.86% decline from fiscal 2022.
- OCUGEN, INC. other noncash income (expense) for fiscal 2022 was $671.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$21.00K 10-Q · filed 2026-08-06 | -$1.03M derived: sum of 3 quarters · filed 2026-08-06 | -$1.04M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-08 | -$1.02M derived: sum of 2 quarters · filed 2026-05-08 | -$1.03M derived: sum of 3 quarters · filed 2026-05-08 | -$1.04M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.02M derived: sum of 2 quarters · filed 2026-03-04 | -$1.03M derived: sum of 3 quarters · filed 2026-08-06 | -$1.04M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$19.00K derived: sum of 2 quarters · filed 2026-08-06 | -$29.00K 10-Q · filed 2025-11-05 | -$38.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$20.00K 10-Q · filed 2026-08-06 | -$29.00K derived: sum of 3 quarters · filed 2026-08-06 | -$38.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$10.00K 10-Q · filed 2026-05-08 | -$19.00K derived: sum of 2 quarters · filed 2026-05-08 | -$28.00K derived: sum of 3 quarters · filed 2026-05-08 | -$38.00K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$18.00K derived: sum of 2 quarters · filed 2026-03-04 | -$28.00K derived: sum of 3 quarters · filed 2026-03-04 | -$37.00K 10-K · filed 2026-03-04 | |||
| 2024-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$19.00K derived: sum of 2 quarters · filed 2025-11-05 | -$28.00K 10-Q · filed 2025-11-05 | $305.00K derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$19.00K 10-Q · filed 2025-08-04 | $314.00K derived: sum of 3 quarters · filed 2025-08-04 | $374.00K derived: sum of 4 quarters · filed 2025-08-04 | |||
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-09 | $324.00K derived: sum of 2 quarters · filed 2025-05-09 | $384.00K derived: sum of 3 quarters · filed 2025-05-09 | $297.00K derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $393.00K derived: sum of 2 quarters · filed 2025-03-05 | $306.00K derived: sum of 3 quarters · filed 2025-03-05 | -$46.00K 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$27.00K derived: sum of 2 quarters · filed 2024-11-14 | -$379.00K 10-Q · filed 2024-11-14 | -$381.00K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$439.00K 10-Q · filed 2024-08-08 | -$441.00K derived: sum of 3 quarters · filed 2024-08-08 | $232.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$352.00K 10-Q · filed 2024-05-14 | -$354.00K derived: sum of 2 quarters · filed 2024-05-14 | $319.00K derived: sum of 3 quarters · filed 2024-05-14 | $319.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $671.00K derived: sum of 2 quarters · filed 2024-04-16 | $671.00K derived: sum of 3 quarters · filed 2024-04-16 | $671.00K 10-K · filed 2024-04-16 | -$479.00K 10-K · filed 2023-02-28 | ||
| 2022-09-30 | $673.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | $673.00K derived: sum of 2 quarters · filed 2024-04-16 | $673.00K 10-K · filed 2024-04-16 | $647.00K derived: sum of 4 quarters · filed 2024-04-16 | |||
| 2022-06-30 | $0.00 derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | $0.00 10-K · filed 2024-04-16 | -$26.00K derived: sum of 3 quarters · filed 2024-04-16 | -$26.00K derived: sum of 4 quarters · filed 2024-04-16 | |||
| 2022-03-31 | $0.00 10-K · filed 2024-04-16 | -$26.00K derived: sum of 2 quarters · filed 2024-04-16 | -$26.00K derived: sum of 3 quarters · filed 2024-04-16 | ||||
| 2021-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$26.00K derived: sum of 2 quarters · filed 2023-02-28 | -$26.00K 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | ||||||
| 2020-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $183.00K derived: sum of 2 quarters · filed 2022-02-28 | $349.00K 10-K · filed 2022-02-28 | $349.41K 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $166.00K 10-Q · filed 2021-11-09 | $165.61K 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $166.00K 10-Q · filed 2021-08-06 | $165.61K 10-Q · filed 2020-08-14 | |||||
| 2019-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$5.00K derived: sum of 2 quarters · filed 2022-02-28 | -$5.00K 10-K · filed 2022-02-28 | -$4.80K 10-K · filed 2021-03-19 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |